US Presidential visit to UK underlines cooperation in science, innovation and higher education

26 May 2011

The joint statement agreed yesterday by UK Prime Minister David Cameron and US President Barack Obama, during the latter’s State Visit to Britain, will strengthen collaboration in science and higher education. Prime Minister Cameron and President Obama agree that science and higher education are the foundation stones of their two nations’ 21st century economies and that the UK and USA have a responsibility to further their global leadership roles in these essential fields.

The agreement will see the UK and the USA increasing the links between their higher education institutions, including through increased post-graduate student and researcher exchange programs. Both countries will also collaborate on a number of significant research projects, including a pharmaceutical partnership, and will embark together on an ambitious programme to create the world’s first combined space weather model.

UK Universities and Science Minister David Willetts said: “Our most productive science and higher education relationship is with the USA and we are determined to strengthen it further. As globalization gathers pace international cooperation in these areas has become even more important to boost Britain’s economic growth, and they are a key part of our overall relationship with the United States.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight



More Features in Pharmaceutical